Share
   
Title
Code
Session Type
Venue
Date Time
Chair:
13:00
TUPDA0101
Association between immunogenetic factors and post-treatment control of HIV-1 infection. ANRS VISCONTI and PRIMO studies
Asier Saéz-Cirión, Insitut Pasteur, France
Abstract
13:05
TUPDA0102
HCV treatment with direct-acting antivirals (DAAs) in HIV/HCV coinfected subjects affects the dynamics of the HIV-1 reservoir
Natalia Laufer, INBIRS Institute (UBA-CONICET), Argentina
Abstract
Slides
13:10
TUPDA0103
IL-10 contributes to, and is a biomarker for, viral persistence in ART-treated, SIV-infected rhesus macaques
Mirko Paiardini, Emory University, United States
Abstract
Slides
13:15
TUPDA0104
Follicular CD8+ T-cells in gut-associated lymphoid tissue are associated with lower HIV-1 reservoir in the terminal ileum after ART initiated during primary HIV infection
John Patrick Thornhill, Imperial College London, United Kingdom
Abstract
Slides
13:20
TUPDA0105
HIV-1 reservoir diversity and genetic compartmentalization in blood and testis
Rosalie Ponte, The Research Institute of the McGill University Health Centre, Canada
Abstract
Slides
13:25
TUPDA0106LB
Ixazomib reduces HIV-1 reservoir size in a Casp8p41-dependent manner
Nathan Cummins, Mayo Clinic, United States
Abstract
Slides
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT